Cory Brown
Foot & Ankle Surgery · Lewiston, IDNPI 1154662948
Payments from drug & device makers
What this record shows
The money is spread across several categories — education (45.0%), food and beverage and travel and lodging — rather than concentrated in one kind of arrangement. 8 manufacturers reported payments, led by Summit Surgical Corp. at 46.1% of the total. Reporting peaked in 2022 at $1,411 and has fallen 97.6% since, to $34 in 2025. That places this record below the midpoint for foot & ankle surgery clinicians in ID, where the typical reported total is $3,361.
Across 22 payments — averaging $121.18 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Summit Surgical Corp.$1K
- Trilliant Surgical LLC.$741
- Stryker$426
- Acera Surgical, Inc.$183
- Organogenesis Inc.$40
- Urgo Medical North America, LLC$18
- plus $30 from 2 others
What the payments were for
- Travel & lodging$57322%
- Food & beverage$74928%
- Education$1,20045%
- Gifts$1435%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Summit Surgical Corp. | 2 | $1,228 |
| Trilliant Surgical LLC. | 4 | $741 |
| Stryker | 9 | $426 |
| Acera Surgical, Inc. | 2 | $183 |
| Organogenesis Inc. | 2 | $40 |
| Urgo Medical North America, LLC | 1 | $18 |
| Treace Medical Concepts, Inc. | 1 | $16 |
| Merck | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Arsenal$317
- Restrata Wound Matrix$122
How this compares
$2,666 in reported general payments places this provider in the 35th percentile of 49 foot & ankle surgery providers in Idaho.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Ketoconazole | 36 | $1,066 |
| Allopurinol | 23 | $206 |
| Triamcinolone Acetonide | 16 | $171 |
| Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim | 14 | $96 |
| Gabapentin | 13 | $78 |
| Cephalexin | 18 | $75 |
Paid to pharmacies, not to this prescriber.
Other foot & ankle surgery in Lewiston
- Gregory GoseyLewiston$12K
- Timothy FlockLewiston$5K
- Kaitlin NearyBoise$867K
- Dan RobinsonBlackfoot$170K
- Kurt KinghornMeridian$150K
- Steven RoserBoise$102K
- Bryan VandykeIdaho Falls$47K
- Jonathon WolfMeridian$22K
- Christopher ArenaCoeur D Alene$14K
- Karson HowardPocatello$14K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.